San Jose, Calif. – 24 Feb 2017 – VMDOC®, a SMART Patient Care Management platform announced interoperability with leading EHR system provider, Elation Health, to enhance the services to patients and providers. The strategic partnership offers providers a more efficient workflow, long-term cost savings, and a comprehensive view of the patients throughout the continuum of care.
Elation Health, is a certified leading electronic health record (EHR) system dedicated to strengthen the patient-physician relationship, providing an intuitive care platform that allows physicians to focus on their patients and deliver high-quality care. The company concentrates on independent primary care practices and other innovative care models, with a network of over 200,000 providers.
In addition, VMDOC proudly extends its partnership network by adding three major specialty laboratories:
Armune BioScience, a leading technology that leverages the immune system’s early warning signals. Armune provides a test called APIFINY® which is the only cancer specific, non-PSA blood test technology that may aid clinicians in the assessment of risk for the presence of prostate cancer. APIFINY blood tests measure unique biological markers known to be associated with an immune system response to prostate cancer. Test results may provide clinicians with additional insight into a patient’s risk, which may aid in a clinical decision for determining next steps.
Invitae, a leading name in Genetic testing is a carefully designed menu of tests to address the patient’s needs in hereditary cancer, cardiology, neurology, pediatrics and more. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic into a single service with better quality, faster turnaround time, and a lower price than the most single gene tests today.
Pacific Edge, Pacific Edge is a cancer diagnostics company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. specializing in discovering, building and commercializing innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer.